Skip to main content
رجوع
Watch Compare

Tenaya Therapeutics, Inc.

جودة البيانات: 83%
TNYA
NASDAQ Manufacturing Chemicals
KWD 0.77
▲ KWD 0.03 (4.19%)
6 months return
—
Momentum
Neutral
ROE
-99.18%

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-99.18%
أقل من متوسط القطاع (-54.68%)
ROIC-73.27%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio4.64
Interest CoverageN/A

التقييم

PE (TTM|NTM)
-1.77 | -1.70
أقل من متوسط القطاع (-1.50)
P/B Ratio1.94
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -68.88 M

Price History

الاتجاهات المالية

السعر المستهدف للمحللين

7 محللين
Buy
+1068.8%
upside to target
الحالي
KWD 0.77
Consensus Target
KWD 9.00
KWD 2.00
أدنى
KWD 40.00
أعلى
التوقعات
مكرر الربحية المستقبلي
-1.70
ربحية السهم المستقبلية
-KWD 0.45
الإيرادات المقدّرة
0.0

مفاجآت الأرباح

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -KWD 0.09 · Rev Est: 7.50 M
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -KWD 0.24 -KWD 0.14 -KWD 0.12 -KWD 0.12 — —
Estimate -KWD 0.21 -KWD 0.19 -KWD 0.15 -KWD 0.12 -KWD 0.09 -KWD 0.11
المفاجأة -17.07% +24.83% +19.33% +1.03% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -99.18% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -90.60 M
ROE -99.18% ROA -79.78%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -68.88 M
ROIC -73.27% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 4.64
Debt / Equity N/A Current Ratio 4.64
Interest Coverage N/A Asset Turnover N/A
Working Capital 48.03 M Tangible Book Value 82.87 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -1.77 · EV/EBITDA: N/A
P/E Ratio -1.77 Forward P/E -1.70
P/B Ratio 1.94 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -42.86%
Market Cap 160.71 M Enterprise Value 104.40 M

Per Share

EPS: -0.59 · FCF/Share: -0.32
EPS (Diluted TTM) -0.59 Revenue / Share N/A
FCF / Share -0.32 OCF / Share -0.31
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 76.03% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 76.03%
SBC-Adj. FCF -83.09 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -90.60 M -111.13 M -124.08 M -123.67 M -72.72 M
EPS (Diluted) -0.59 -1.31 -1.68 -2.76 —
Gross Profit — — — — —
Operating Income -93.33 M -115.95 M -131.19 M -125.62 M -72.81 M
EBITDA — — — — —
R&D Expenses 68.61 M 86.74 M 98.04 M 94.54 M 54.39 M
SG&A Expenses — — — — —
D&A 8.44 M 8.47 M 8.69 M 6.47 M 2.96 M
Interest Expense — — — — —
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 146.92 M 119.94 M 170.52 M 278.95 M 314.19 M
Total Liabilities 23.66 M 27.09 M 31.09 M 35.57 M 35.66 M
Shareholders' Equity 123.27 M 92.85 M 139.42 M 243.38 M 278.53 M
Total Debt — — — — —
Cash & Equivalents 100.55 M 4.32 M 45.68 M 95.27 M 38.13 M
Current Assets 105.59 M 67.38 M 111.58 M 193.75 M 255.36 M
Current Liabilities 15.44 M 15.98 M 22.73 M 24.25 M 21.77 M

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1605 نظير)
المقياس السهم وسيط القطاع
P/E -1.8 -1.5
P/B 1.9 1.6
ROE % -99.2 -54.7
Net Margin % — -41.5
Rev Growth 5Y % — 1.7
D/E — 0.3